As the incidence of the COVID-19 pandemic increases in U.S. communities, the needs of cancer patients, and those caring for them, are at the forefront of our attention and action.
The National Comprehensive Cancer Network has published a curated list of high-impact measures for assessing quality improvements in cancer care.
Researchers from the David Geffen School of Medicine at UCLA and UCLA Jonsson Comprehensive Cancer Center have received a $2.7 million grant from NCI to develop techniques to improve the quality of prostate magnetic resonance imaging and new artificial intelligence methods that use prostate MRI to assist cancer diagnosis.
FDA has issued a final rule that requires health warnings on cigarette packages and in cigarette advertisements.
When The Cancer Letter spoke with Giuseppe Curigliano last week, he described the atmosphere in Italy as “spectral.”
The predicament in which Janice Cowden finds herself is so ordinary in today’s pandemic-struck America that it’s repeated thousands of times—and therein lies its horror.
Early data from China and Italy confirm that cancer patients are at higher risk for developing severe adverse events and dying after testing positive for the novel coronavirus.
As the crisis triggered by the COVID-19 pandemic deepens, the two separate, unequal societies that make up the United States of America are equally frightened, bewildered, and unsure of what comes next.
The worldwide spread of the coronavirus (COVID-19) presents unprecedented challenges to the cancer care delivery system.
